Aromatic-Cationic Peptides for DMD Muscle Stabilization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Duchenne muscular dystrophy (DMD) is an incurable illness characterized by progressive muscle degeneration and weakness, primarily due to mutations in the dystrophin gene, leading to severe muscle damage, cardiomyopathy, and premature death.
Innovation Solution
Administration of a therapeutically effective amount of aromatic-cationic peptides, such as 2′6′-Dmt-D-Arg-Phe-Lys-NH2, Phe-D-Arg-Phe-Lys-NH2, or D-Arg-2′6′-Dmt-Lys-Phe-NH2, or their pharmaceutically acceptable salts, to subjects with DMD, which can normalize creatine phosphokinase blood levels, increase utrophin expression, and potentially delay disease progression.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If aromatic-cationic peptides are administered to DMD subjects, then muscle damage is reduced and muscle function is improved, but the disease progression cannot be completely halted
Solution Approach 1:
The aromatic-cationic peptides are administered to prevent muscle damage before it occurs by stabilizing the dystrophin-glycoprotein complex and reducing mechanical stress on muscle fibers, thereby ameliorating disease symptoms and improving muscle function in DMD subjects
2Strength
If dystrophin production is disrupted by genetic mutations, then muscle structural stability is compromised, but utrophin expression can be increased as compensation
Solution Approach 1:
The aromatic-cationic peptides act as intermediaries that bind to the dystrophin-glycoprotein complex and enhance its stability and function, compensating for reduced dystrophin levels and improving muscle structural integrity in DMD subjects
Solution Approach 2:
The peptides induce parameter changes in muscle tissue by increasing utrophin expression levels and altering the mechanical properties of the muscle fiber membrane, thereby compensating for dystrophin deficiency and improving muscle strength
3Object-affected harmful factors
If muscle fibers are subjected to mechanical injury without dystrophin, then necrosis occurs and muscles are replaced with adipose tissue, but therapeutic peptides can reduce this damage
Solution Approach 1:
The aromatic-cationic peptides provide beforehand cushioning by stabilizing the muscle fiber membrane and dystrophin-glycoprotein complex before mechanical injury occurs, reducing susceptibility to damage and preventing necrosis in DMD muscle fibers
Data Source
AI summary
The disclosure provides methods of preventing or treating DMD in a mammalian subject, reducing risk factors associated with DMD, and/or reducing the likelihood or severity of DMD. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide.